Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reeder M Robinson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Archives of Biochemistry and Biophysics|April 29, 2014
Mechanistic studies on the flavin-dependent N⁶-lysine monooxygenase MbsG reveal an unusual control for catalysisReeder M Robinson, Pedro J Rodriguez, Pablo Sobrado
Protein Science : a Publication of the Protein Society|August 12, 2018
Flavin oxidation in flavin-dependent N-monooxygenasesReeder M Robinson, Catherine A Klancher, Pedro J Rodriguez, et al.
Archives of Biochemistry and Biophysics|January 30, 2013
Tryptophan-47 in the active site of Methylophaga sp. strain SK1 flavin-monooxygenase is important for hydride transferAndre Han, Reeder M Robinson, Somayesadat Badieyan, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2022
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myelomaReeder M Robinson, Ashton P Basar, Leticia Reyes, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
Journal of the American Chemical Society|October 6, 2012
Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutaseRicha Dhatwalia, Harkewal Singh, Luis M Solano, et al.
Biomolecules|January 25, 2025
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell LymphomaNadia St Thomas, Benjamin N Christopher, Leticia Reyes, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Cancer Research|June 21, 2020
ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase InhibitorsRavyn M Duncan, Leticia Reyes, Katelyn Moats, et al.
Blood Cancer Journal|November 18, 2025
A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemiaLena Golick, Reeder M Robinson, Leticia Reyes, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Archives of Biochemistry and Biophysics|April 29, 2014
Mechanistic studies on the flavin-dependent N⁶-lysine monooxygenase MbsG reveal an unusual control for catalysisReeder M Robinson, Pedro J Rodriguez, Pablo Sobrado
Protein Science : a Publication of the Protein Society|August 12, 2018
Flavin oxidation in flavin-dependent N-monooxygenasesReeder M Robinson, Catherine A Klancher, Pedro J Rodriguez, et al.
Archives of Biochemistry and Biophysics|January 30, 2013
Tryptophan-47 in the active site of Methylophaga sp. strain SK1 flavin-monooxygenase is important for hydride transferAndre Han, Reeder M Robinson, Somayesadat Badieyan, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2022
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myelomaReeder M Robinson, Ashton P Basar, Leticia Reyes, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
Journal of the American Chemical Society|October 6, 2012
Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutaseRicha Dhatwalia, Harkewal Singh, Luis M Solano, et al.
Biomolecules|January 25, 2025
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell LymphomaNadia St Thomas, Benjamin N Christopher, Leticia Reyes, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Cancer Research|June 21, 2020
ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase InhibitorsRavyn M Duncan, Leticia Reyes, Katelyn Moats, et al.
Blood Cancer Journal|November 18, 2025
A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemiaLena Golick, Reeder M Robinson, Leticia Reyes, et al.
Pageof 2